✦ LIBER ✦

Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease

✍ Scribed by Hoyos, Montserrat; Nomdedeu, Josep F.; Esteve, Jordi; Duarte, Rafael; Ribera, Josep M.; Llorente, Andreu; Escoda, Lourdes; Bueno, Javier; Tormo, Mar; Gallardo, David; de Llano, Maria Paz Queipo; Martí, Josep M.; Aventín, Anna; Mangues, Ramón; Brunet, Salut; Sierra, Jorge

Book ID: 120314155
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 189 KB
Volume: 91
Category: Article
ISSN: 0902-4441
DOI: 10.1111/ejh.12130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of residual normal metaphases in

Impact of residual normal metaphases in core binding factor acute myeloid leukemia

✍ Bruno C. Medeiros; Megan Othus; Min Fang; Frederick R. Appelbaum; Elihu H. Estey 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

Prospective evaluation of gene mutations

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

✍ Jourdan, E.; Boissel, N.; Chevret, S.; Delabesse, E.; Renneville, A.; Cornillet, 📂 Article 📅 2013 🏛 American Society of Hematology 🌐 English ⚖ 87 KB

High prognostic value of minimal residua

High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)

✍ Wang, Libing; Gao, Lei; Xu, Sheng; Gong, Shenglan; Liu, Min; Qiu, Huiying; Xu, X 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 688 KB

The kinetics of reduction of minimal res

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia

✍ Buccisano, F; Maurillo, L; Gattei, V; Del Poeta, G; Del Principe, M I; Cox, M C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

Successful donor leukocyte transfusion a

Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay

✍ Ogawa, H; Tsuboi, A; Oji, Y; Tamaki, H; Soma, T; Inoue, K; Sugiyama, H 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB